Analytical Data
-
Gene name
CARNS1
- Application
-
Alternative Names
ATPGD1; ATP-Grasp Domain Containing 1
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ZPS2
-
Expression Region
Ala623~Phe826
-
Molecular Weight
26kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CARNS1, or Cytosolic Arginyl-tRNA Synthetase 1, is an essential enzyme involved in the post-translational modification of proteins by facilitating the addition of arginine to tRNA molecules. This enzymatic activity is crucial for protein synthesis, as it ensures the accurate translation of genetic information into functional proteins. In recent years, research has increasingly focused on CARNS1 due to its emerging role in various cellular processes, including cell proliferation, differentiation, and stress response. Abnormal expression or dysfunction of CARNS1 has been linked to several diseases, including cancer and neurodegenerative disorders, highlighting its potential as a therapeutic target. Moreover, studies have indicated that CARNS1 plays a significant role in regulating amino acid metabolism and maintaining cellular homeostasis. The reconstitution of CARNS1 as a recombinant protein has enabled scientists to investigate its structural and functional properties in greater detail, providing insights into its mechanisms of action and potential interactions with other cellular components. Overall, the study of CARNS1 and its recombinant form represents a promising avenue for understanding fundamental biological processes and developing novel therapeutic strategies.
